Letters Barriers to access of clinical data

GlaxoSmithKline on its remote desktop interface for independent reanalysis of drug trial data

BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g4898 (Published 30 July 2014) Cite this as: BMJ 2014;349:g4898
  1. James Shannon, chief medical officer1
  1. 1GlaxoSmithKline, Brentford TW8 9GS, UK
  1. james.s.shannon{at}gsk.com

We launched our system in May 2013 to provide researchers with access to patient level data from our studies in the belief that greater access to these data would facilitate further research to advance medical science and lead to improvements in patient care. I am sorry that Jureidini and his team have had difficulty working within the system.1 We worked hard to …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe